5453-85-0

Basic information

• Product Name: ethyl cyclopentanecarboxylate
• Synonyms: ethyl cyclopentanecarboxylate;Cyclopentane-1-carboxylic acid ethyl ester
• CAS NO: 5453-85-0
• Molecular Formula: C₈H₁₄O₂
• Molecular Weight: 142.19556
• EINECS: 226-699-4
• Mol File: 5453-85-0.mol
• Article Data: 15

Chemical Properties

• Melting Point: 109 °C
• Boiling Point: 178.1°C at 760 mmHg
• Flash Point: 56.4°C
• Appearance: /
• Density: 0.995g/cm³
• Vapor Pressure: 1.01mmHg at 25°C
• Refractive Index: 1.453
• CAS DataBase Reference: ethyl cyclopentanecarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl cyclopentanecarboxylate(5453-85-0)
• EPA Substance Registry System: ethyl cyclopentanecarboxylate(5453-85-0)

Safety Data

• Hazardous Substances Data: 5453-85-0(Hazardous Substances Data)

Usage

Synthesis Reference(s)

Tetrahedron Letters, 21, p. 2675, 1980 DOI: 10.1016/S0040-4039(00)92837-5

InChI:InChI=1/C8H14O2/c1-2-10-8(9)7-5-3-4-6-7/h7H,2-6H2,1H3

Upstream product

• 1125-99-1 1-(1-Cyclohexen-1-yl)pyrrolidine 
• 64-17-5 ethanol 
• 29512-97-8 2,6-Dibromhexansaeure-ethylester 
• 4524-93-0 Cyclopentanecarboxylic acid chloride 
• 611-10-9 2-ethoxycarbonyl-1-cyclopentanone 
• 142-29-0 cyclopentene 
• 7664-93-9 sulfuric acid 
• 624-85-1 ethyl hypochlorite 
• 108-94-1 cyclohexanone 
• 122-51-0 orthoformic acid triethyl ester 
• 112162-95-5 ethyl N-tosylcyclopentanecarbimidate 
• 541-41-3 chloroformic acid ethyl ester 
• 4167-77-5 cyclopentane-1,1-dicarboxylic acid diethyl ester 
• 822-87-7 2-Chlorocyclohexanone 

Downstream Products

• 30038-94-9 1-bromocyclopentane-carboxylic acid ethyl ester 
• 33537-18-7 cyclopentyl-oxo-acetic acid ethyl ester 
• 3637-61-4 1-amino-cyclopentanemethanol 
• 6703-81-7 11-cyclopentyl-heneicosane 
• 1462-06-2 1-cyclopentyl-1-methylethanol 
• 1215295-95-6 7-azaspiro[4.5]decan-6-one 

Relevant articles and documents

CASPASE INHIBITOR AND PHARMACEUTICAL COMPOSITION, USE AND THERAPEUTIC METHOD THEREOF

Disclosed are a class of compounds as a caspase inhibitor, and in particular the compound as shown in formula (I) or a pharmaceutically acceptable salt thereof, and the use of the compound in treating caspase-related diseases.

PYRAZOLE AMIDE DERIVATIVE

The present invention relates to a novel compound having a function of inhibiting RORγ activity. The present invention also relates to pharmaceutical composition comprising the compound, a use of the compound in treating or preventing autoimmune diseases, inflammatory diseases, metabolic diseases, or cancer diseases.

CYCLOALKYL METHOXYBENZYL PHENYL PYRAN DERIVATIVES AS SODIUM DEPENDENT GLUCOSE CO TRANSPORTER (SGLT2) INHIBITORS

The invention relates to the cycloalkyl methoxybenzyl phenyl pyran derivatives as Sodium dependent glucose co transporter (SGLT) inhibitors, particularly SGLT2 and method of treating diseases, conditions and/or disorders inhibited by SGLT2 with them, and processes for preparing them.